Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
Adolescent
Adult
Botswana
Contraceptive Agents, Female
/ administration & dosage
Counseling
/ education
Cross-Sectional Studies
Female
Health Services Accessibility
/ organization & administration
Humans
Intrauterine Devices
/ statistics & numerical data
Long-Acting Reversible Contraception
/ methods
Pregnancy
Surveys and Questionnaires
Young Adult
Adolescent
Botswana
IUD
Implant
LARC
Long-acting reversible contraceptives
Journal
Journal of pediatric and adolescent gynecology
ISSN: 1873-4332
Titre abrégé: J Pediatr Adolesc Gynecol
Pays: United States
ID NLM: 9610774
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
07
12
2020
revised:
08
03
2021
accepted:
15
03
2021
pubmed:
27
3
2021
medline:
17
7
2021
entrez:
26
3
2021
Statut:
ppublish
Résumé
Botswana has a high pregnancy rate among adolescent girls and young women (AGYW). Long-acting reversible contraceptive (LARC) use among AGYW in Botswana is low, despite its high effectiveness for preventing pregnancy. Using an implementation science framework, we assessed barriers and facilitators to LARC implementation among AGYW in Botswana. Cross-sectional mixed methods. Gaborone, Botswana. Twenty sexually active AGYW ages 18-24 years; 20 health system stakeholders. Surveys and semistructured interviews grounded in the Consolidated Framework for Implementation Research. Themes reflecting barriers and facilitators of LARC implementation. The median age for AGYW was 22 (interquartile range, 21-23) years. Twenty percent were using an implant and none had ever used an intrauterine device. Barriers and facilitators of LARC implementation spanned factors at each Consolidated Framework for Implementation Research domain: (1) LARC characteristics like side effects; (2) the clinics' inner settings, including availability of youth-friendly services; (3) characteristics of health system stakeholders, such as LARC skills, and AGYW experiences, attitudes, and beliefs about LARCs; (4) the outer setting external to clinics and Botswana's health system including reproductive health law and policy for minor adolescents; and (5) the implementation process level such as the availability of free or low-cost LARCs. We identified multilevel, context-specific factors that affect LARC implementation. Our findings can inform the development of interventions to increase LARC implementation in Botswana by addressing intersecting factors across patient, clinic, health system, and sociopolitical levels, such as providing confidential services to minors and improving LARC training and supply chain pipelines.
Identifiants
pubmed: 33766793
pii: S1083-3188(21)00155-8
doi: 10.1016/j.jpag.2021.03.005
pmc: PMC8277689
mid: NIHMS1686477
pii:
doi:
Substances chimiques
Contraceptive Agents, Female
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
504-513Subventions
Organisme : NIMH NIH HHS
ID : K23 MH119976
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Afr J Reprod Health. 2018 Jun;22(2):76-82
pubmed: 30052336
Pediatrics. 2014 Oct;134(4):e1244-56
pubmed: 25266430
Reprod Health. 2019 May 29;16(Suppl 1):61
pubmed: 31138307
Matern Child Health J. 2017 Sep;21(9):1734-1743
pubmed: 27154524
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Int J Health Plann Manage. 2018 Oct;33(4):e1037-e1049
pubmed: 30047594
SAHARA J. 2013;10(2):83-8
pubmed: 24405283
Glob Health Sci Pract. 2018 Oct 4;6(3):500-514
pubmed: 30287529
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obstet Gynecol. 2018 May;131(5):947-948
pubmed: 29683905
J Adolesc Health. 2017 Feb;60(2):161-168
pubmed: 27863929
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):458-466
pubmed: 30085953